Skip to content
The U.S. Food and Drug Administration (FDA) has received Moderna’s application for emergency use authorization for its bivalent booster vaccine, mRNA-1273.222, which targets the […]
Moderna’s bivalent booster awaits emergency use authorization Read More »
Updated efficacy data from a Phase 2/3 trial testing three 3-g doses of the Pfizer-BioNTech COVID-19 vaccine in children aged 6 months to 4
Pfizer: COVID-19 vaccine effective in children 6 months to 4 years Read More »
Biotech partners Pfizer and BioNTech announced on Monday that they have requested Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA)
Pfizer-BioNTech requests federal authorization for Omicron-adapted booster Read More »
The practice of making drug makers give rebates to payers encourages Medicare Part D insurers to steer patients away from generic drugs that cost
HHS probe: Insurer PBMs pocket rebates as patients, taxpayers pay more Read More »
Despite the advancement of prevention, detection, and early treatment options for many cervical cancers, late-stage cervical cancer diagnoses are up in the United States,
Late-stage cervical cancer on the rise despite jab, early treatment options Read More »
The European Commission (EC) has granted Marketing Authorization for the first twice-yearly HIV therapy, Sunlenca (lenacapavir), developed by Gilead Sciences, the biopharmaceutical company announced
Sunlenca, the first twice-yearly HIV therapy, approved by European Commission Read More »
The U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Novavax COVID-19 vaccine Adjuvanted (NVX-CoV2373) “for the prevention of Coronavirus Disease
Novavax COVID vaccine granted EUA for adolescents ages 12 to 17 Read More »
The Inflation Reduction Act, passed August 7, 2022, will hit biotech innovation hard by enacting drug price controls on around 100 drugs over the
Who the Inflation Reduction Act helps Read More »
Faced with the surging number of monkeypox cases in the U.S, the White House announced new actions on Thursday to accelerate the distribution of
The U.S. pharmaceutical giant and Biotechnology Innovation Organization’s (BIO) member Merck announced on Tuesday its collaboration agreement with the biotech startup Orna Therapeutics, which
Merck to help Orna Therapeutics advance ‘circular RNA’ technology Read More »
